Published
June 13, 2025
Updated
July 29, 2026
West Virginia reserved $3,819,250 for consumers who allegedly overpaid for branded Lipitor before generic competition; the July 2025 claim period is closed.
Current Status
The consumer claim deadline passed July 28, 2025. West Virginia announced distributions to government entities in May 2025, but the official consumer claim site has not posted a public date confirming that individual consumer payments were issued.StatusClaims closed; consumer payment update not posted
Claim DeadlineJuly 28, 2025 (Passed)
BenefitUp to $599 for an approved consumer claim
Proof RequiredReceipts were not required
What Was This Matter About?
West Virginia alleged that Pfizer- and Ranbaxy-related companies delayed lower-cost generic competition for Lipitor, causing consumers and public entities to pay more. The settling companies did not admit liability.Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Who Could File?
The consumer process covered people who bought branded Lipitor in West Virginia and paid some or all of the cost, including a copay or other out-of-pocket amount, from March 24, 2010 through November 30, 2011.What Happens Next?
New claims are not accepted. Former claimants should rely on the official consumer site for claim-processing or payment updates.Official Information
Review notices and documents on the West Virginia Lipitor Claim website.
Consumer Fund
$3,819,250
Matter
West Virginia Lipitor antitrust settlements
Administrator
ILYM Group
Jurisdiction
State of West Virginia
Current Milestone
Claims closed; consumer distribution update unavailable
Official Website
West Virginia Lipitor Claim
For more class actions, recalls, and refunds, keep scrolling below.
